Paper31202802
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.
Dar MI and 8 others. Eur J Pharmacol, 2019. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells. Papers, record 31202802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31202802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetophenones | Major topic |
| Benzopyrans | Major topic |
| Cell Differentiation | Major topic |
| Neuroblastoma | Major topic |
| Neurons | Major topic |
| Phosphodiesterase Inhibitors | Major topic |
| Phosphoric Diester Hydrolases | Major topic |
| AMP-Activated Protein Kinases | |
| Autophagy | |
| Cell Line, Tumor | |
| G2 Phase Cell Cycle Checkpoints | |
| Humans | |
| Molecular Docking Simulation | |
| Protein Conformation | |
| S Phase Cell Cycle Checkpoints | |
| Signal Transduction |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38539429 | Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell Line. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38539429 | PubMed |
| 37597697 | Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. | Bioorg Med Chem Lett | 2023 | https://conductscience.org/library/papers/37597697 | PubMed |
| 35740338 | Rottlerin Stimulates Exosome/Microvesicle Release Via the Increase of Ceramide Levels Mediated by Ampk in an In Vitro Model of Intracellular Lipid Accumulation. | Biomedicines | 2022 | https://conductscience.org/library/papers/35740338 | PubMed |
| 33177705 | Equivocal, explicit and emergent actions of PKC isoforms in cancer. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/33177705 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALDH7A1 | 501 | PubTator's text mining | https://conductscience.org/library/genes/501 | NCBI Gene |
| PDE4A | 5141 | PubTator's text mining | https://conductscience.org/library/genes/5141 | NCBI Gene |
| PDE5A | 8654 | PubTator's text mining | https://conductscience.org/library/genes/8654 | NCBI Gene |
| PDE7A | 5150 | PubTator's text mining | https://conductscience.org/library/genes/5150 | NCBI Gene |
| PRKAA1 | 5562 | PubTator's text mining | https://conductscience.org/library/genes/5562 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31202802
GET https://conductscience.org/api/papers/v1/31202802/authors